🌎 Hershey Downgraded, Diageo Downgraded, Equinor ASA Downgraded and more...
Ratings changes for Ulta Beauty, MaxCyte, OmniAb, Microsoft, CrowdStrike, Splunk, Affimed and more...Upgrade to MarketBeat All Access to get early delivery, personalized stock alerts, portfolio monitoring tools, and more. Start Your Free Trial. Unsubscribe.
VIEW MY PORTFOLIO
November 29th, 2023
Discover AI Stocks Potentially Ready to Skyrocket in Value! (ad)
With AI's predicted surge to $2 trillion in just 7 years, now might be the prime time to invest. The most affluent future trillionaires? Those who master AI, says Mark Cuban. Don't miss out on our expertly curated list of the Top 5 AI Stocks set for potential monumental growth.
Free Stock Analysis Report: Get Buy, Sell, or Hold Recommendation (ad)
Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.
Microsoft Co. (NASDAQ:MSFT) announced a quarterly dividend on Tuesday, November 28th. Stockholders of record on Thursday, February 15th will be paid a dividend of 0.75 per share by the software giant on Thursday, March 14th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 0.78%. The ex-dividend date of this dividend is Wednesday, February 14th.
Microsoft (NASDAQ:MSFT) had its price target raised by analysts at Tigress Financial ( ) from $433.00 to $475.00. They now have a "buy" rating on the stock. This represents a 23.5% upside from the current price of $384.76.
AvalonBay Communities (NYSE:AVB) was upgraded by analysts at JPMorgan Chase & Co. from an "underweight" rating to a "neutral" rating. They now have a $194.00 price target on the stock, down previously from $201.00. This represents a 12.1% upside from the current price of $173.11.
Bayerische Motoren Werke Aktiengesellschaft (OTCMKTS:BMWYY) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating.The current price is $34.23.
Carlsberg A/S (OTCMKTS:CABGY) was upgraded by analysts at JPMorgan Chase & Co. from an "underweight" rating to a "neutral" rating.The current price is $24.49.
RBC Bearings (NYSE:RBC) was upgraded by analysts at Bank of America Co. from an "underperform" rating to a "buy" rating. They now have a $280.00 price target on the stock, up previously from $230.00. This represents a 10.0% upside from the current price of $254.55.
Tuya (NYSE:TUYA) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $2.70 price target on the stock. This represents a 35.7% upside from the current price of $1.99.
Airbnb (NASDAQ:ABNB) was downgraded by analysts at Jefferies Financial Group Inc. from a "buy" rating to a "hold" rating. They now have a $140.00 price target on the stock, down previously from $155.00. This represents a 10.4% upside from the current price of $126.82.
CAE (NYSE:CAE) (TSE:CAE) was downgraded by analysts at Bank of America Co. from a "neutral" rating to an "underperform" rating.The current price is $19.09.
The Carlyle Group (NASDAQ:CG) was downgraded by analysts at Evercore ISI from an "outperform" rating to an "in-line" rating. They now have a $32.00 price target on the stock. This represents a 7.1% downside from the current price of $34.46.
Diageo (NYSE:DEO) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating.The current price is $139.53.
Equinor ASA (NYSE:EQNR) was downgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to an "underperform" rating.The current price is $32.05.
Hershey (NYSE:HSY) was downgraded by analysts at Piper Sandler from an "overweight" rating to a "neutral" rating. They now have a $200.00 price target on the stock, down previously from $240.00. This represents a 7.2% upside from the current price of $186.56.
Leslie's (NASDAQ:LESL) was downgraded by analysts at The Goldman Sachs Group, Inc. from a "buy" rating to a "neutral" rating. They now have a $5.00 price target on the stock, down previously from $10.00. This represents a 7.1% upside from the current price of $4.67.
NetApp (NASDAQ:NTAP) was downgraded by analysts at Northland Securities from an "outperform" rating to a "market perform" rating. They now have a $100.00 price target on the stock. This represents a 10.3% upside from the current price of $90.63.
Kering (OTCMKTS:PPRUY) was downgraded by analysts at Stifel Nicolaus from a "buy" rating to a "hold" rating.The current price is $43.20.
Splunk (NASDAQ:SPLK) was downgraded by analysts at Truist Financial Co. from a "buy" rating to a "hold" rating. They now have a $157.00 price target on the stock. This represents a 3.9% upside from the current price of $151.09.
TotalEnergies (NYSE:TTE) was downgraded by analysts at Jefferies Financial Group Inc. from a "buy" rating to a "hold" rating.The current price is $67.87.
Volkswagen (OTCMKTS:VWAGY) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating.The current price is $12.90.
Imagine buying one single stock in the next three hours... (ad)
...and changing the trajectory of your family's future forever. It can happen. But the question is... How do you find the right stock? How do we go about identifying the stock with the best chance to get us there? That's what I'm going to share with you today. You see... I've found the next stock that I believe has just as much potential as (perhaps more than) Berkshire Hathaway, Apple, Netflix or Amazon.
Alexander & Baldwin (NYSE:ALEX) is now covered by analysts at JMP Securities. They set a "market perform" rating on the stock.The current price is $16.54.
Cabaletta Bio (NASDAQ:CABA) is now covered by analysts at William Blair. They set an "outperform" rating and a $38.00 price target on the stock. This represents a 147.2% upside from the current price of $15.37.
Cardlytics (NASDAQ:CDLX) is now covered by analysts at Lake Street Capital. They set a "buy" rating and a $13.00 price target on the stock. This represents a 62.9% upside from the current price of $7.98.
GitLab (NASDAQ:GTLB) is now covered by analysts at Raymond James. They set a "market perform" rating on the stock.The current price is $49.37.
Korro Bio (NASDAQ:KRRO) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $70.00 price target on the stock. This represents a 77.2% upside from the current price of $39.50.
Moderna (NASDAQ:MRNA) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "hold" rating and a $82.00 price target on the stock. This represents a 3.3% upside from the current price of $79.41.
Moderna (NASDAQ:MRNA) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "hold" rating and a $82.00 price target on the stock. This represents a 3.3% upside from the current price of $79.41.
MedEquities Realty Trust (NYSE:MRT) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $0.90 price target on the stock. This represents a 42.9% upside from the current price of $0.63.
Microvast (NASDAQ:MVST) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $8.00 price target on the stock. This represents a 592.6% upside from the current price of $1.16.
MaxCyte (NASDAQ:MXCT) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $7.00 price target on the stock. This represents a 41.7% upside from the current price of $4.94.
OmniAb (NASDAQ:OABI) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $6.00 price target on the stock. This represents a 35.1% upside from the current price of $4.44.
SOPHiA GENETICS (NASDAQ:SOPH) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $8.00 price target on the stock. This represents a 94.6% upside from the current price of $4.11.
Spyre Therapeutics (NASDAQ:SYRE) is now covered by analysts at TD Cowen. They set an "outperform" rating on the stock.The current price is $15.73.
Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:
Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.
Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET.
UPGRADE NOW
Manage Your Watchlist
View and add up to five holdings to your watchlist.
VIEW MY PORTFOLIO
Join Our Facebook Group
Join MarketBeat's free stock discussion and trading idea group on Facebook.
JOIN NOW
Thank you for subscribing to MarketBeat!
We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.
No comments:
Post a Comment